trial · primary record
CTI-1601
Friedreich Ataxia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 85 |
| Primary completion | 2027-01 |
| Primary endpoint | Number of subjects with treatment-emergent adverse events (TEAEs) by System Organ Class (SOC), Preferred Term (PT) and Maximum Severity |
| Registry ID | NCT06447025 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:13.954Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06447025
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.